PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
Ccent/2022/31 - BSC / M.I. Tech
Acquiring
Boston Scientific Corporation
Description
Company active in the development, manufacture and sale of medical devices for medical intervention specialties, including intervention in cardiology, endovascular intervention, electrophysiology, endoscopy, radiology/oncology, urology, pulmonary endoscopy and neuromodulation.
Acquired
M.I. Tech Co., Ltd.
Description
South Korean company that develops, manufactures and supplies medical devices in the field of digestive endoscopy. In Portugal, the activities of M.I. Tech are limited to the supply of bare metal stents for gastrointestinal interventions that are marketed through various external distributors.
Sector
Activity (NACE)
Applicable legislation
Notification thresholds
Type of merger
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 2 - In-depth investigation
AdC’s decision
Withdrawn
Case description

The notified concentration consists of the acquisition of sole control over M.I. Tech by Boston Scientific Corporation.
Timeline
2023-05-17
The AdC announced that the procedure initiated to assess the Merger BSC / M.I. Tech has been withdrawn.
2022-12-16
Phase I Decision - The Board of the Competition Authority decided to proceed to an in-depth investigation into the merger BSC / M.I. Tech.
2022-07-26
The BSC notifies the acquisition of sole control over M.I. Tech.
Click here to see your activities